Prabhudas S Patel Selected Research

Precancerous Conditions

1/2018	Role of aberrant glycosylation enzymes in oral cancer progression.
12/2014	Salivary glyco-sialylation changes monitors oral carcinogenesis.
6/2013	Evaluation of serum and salivary total sialic acid and α-l-fucosidase in patients with oral precancerous conditions and oral cancer.
7/2008	Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
4/2008	Tissue and serum alpha 2-3- and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis.
1/2002	Vitamin B(12) and Folate Status in Head and Neck Cancer.
7/2001	A Study of Various Sociodemographic Factors and Plasma Vitamin Levels in Oral and Pharyngeal Cancer in Gujarat, India.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Prabhudas S Patel Research Topics

Disease

23	Mouth Neoplasms (Oral Cancer) 02/2021 - 01/2005
22	Neoplasms (Cancer) 02/2021 - 07/2001
10	Neoplasm Metastasis (Metastasis) 03/2020 - 05/2005
8	Carcinogenesis 01/2018 - 12/2007
7	Precancerous Conditions 01/2018 - 07/2001
4	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2009
3	Carcinoma (Carcinomatosis) 01/2021 - 07/2008
3	Disease Progression 03/2020 - 01/2002
3	Squamous Cell Carcinoma of Head and Neck 04/2016 - 05/2005
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 01/2014
2	Head and Neck Neoplasms (Head and Neck Cancer) 12/2002 - 01/2002
2	Melanoma (Melanoma, Malignant) 09/2002 - 04/2002
1	Tongue Neoplasms (Tongue Neoplasm) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2020
1	Infections 11/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2019
1	Blast Crisis (Blast Phase) 01/2014
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2012
1	Cystinosis 01/2012
1	Breast Diseases (Breast Disease) 01/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2008

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 11/2020 - 04/2002
9	Biomarkers (Surrogate Marker)IBA 02/2021 - 04/2007
6	AntioxidantsIBA 01/2012 - 01/2005
5	N-Acetylneuraminic Acid (Sialic Acid)IBA 07/2016 - 05/2005
5	Matrix Metalloproteinases (MMPs)IBA 01/2012 - 05/2005
4	RNA (Ribonucleic Acid)IBA 11/2020 - 10/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 09/2002
4	Neuraminidase (Sialidase)IBA 03/2020 - 12/2014
4	EnzymesIBA 01/2018 - 01/2005
3	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 01/2014
3	SialyltransferasesIBA 03/2020 - 04/2008
3	Messenger RNA (mRNA)IBA 03/2020 - 09/2002
3	alpha-L-Fucosidase (Fucosidase)IBA 01/2018 - 07/2008
3	Glycoproteins (Glycoprotein)IBA 01/2017 - 07/2008
3	SialoglycoproteinsIBA 07/2016 - 04/2008
3	NF-kappa B (NF-kB)IBA 04/2016 - 04/2002
3	theasinensin AIBA 12/2014 - 04/2008
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2009 - 12/2002
3	Sulfhydryl Compounds (Thiols)IBA 10/2008 - 01/2005
2	Protein Isoforms (Isoforms)IBA 11/2020 - 08/2015
2	Vitamin D FDA LinkGeneric 01/2020 - 01/2012
2	LipidsIBA 07/2016 - 05/2005
2	Biological ProductsIBA 01/2012 - 01/2005
2	Tissue Inhibitor of Metalloproteinase-1IBA 01/2011 - 07/2010
2	Tissue Inhibitor of Metalloproteinase-2IBA 01/2011 - 07/2010
2	CatalaseIBA 10/2009 - 10/2008
2	Vitamin E FDA LinkGeneric 01/2009 - 07/2001
2	Capsaicin (Zostrix)FDA Link 09/2002 - 04/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2002 - 04/2002
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	buteinIBA 01/2021
1	3,3',4,5'-tetrahydroxystilbeneIBA 01/2021
1	CurcuminIBA 01/2021
1	hydroxide ionIBA 01/2020
1	Glycoside Hydrolases (Endoglycosidases)IBA 01/2018
1	GlycosyltransferasesIBA 01/2018
1	Sialyl Lewis X AntigenIBA 01/2017
1	SelectinsIBA 01/2017
1	LigandsIBA 01/2017
1	Cell Adhesion MoleculesIBA 01/2017
1	OligosaccharidesIBA 07/2016
1	GlycolipidsIBA 07/2016
1	SugarsIBA 07/2016
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 07/2016
1	Sialic AcidsIBA 07/2016
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 07/2016
1	ProstaglandinsIBA 04/2016
1	NitrogenIBA 04/2016
1	Oxygen (Dioxygen)IBA 04/2016
1	MicroRNAs (MicroRNA)IBA 04/2016
1	CytokinesIBA 04/2016
1	Codon (Codons)IBA 01/2016
1	VimentinIBA 01/2015
1	Keratins (Keratin)IBA 01/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	ParaffinIBA 01/2015
1	TransferasesIBA 12/2014
1	Proline (L-Proline)FDA Link 01/2013
1	Cysteamine (Mercaptamine)FDA Link 01/2012
1	matrigelIBA 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 10/2011
1	Tumor Biomarkers (Tumor Markers)IBA 10/2011
1	N 30IBA 10/2009
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2009
1	DNA AdductsIBA 01/2009
1	vitamin E drug combination vitamin AIBA 01/2009
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2009
1	Vitamin A (Retinol)FDA LinkGeneric 01/2009
1	beta Carotene (Betacarotene)FDA Link 01/2009
1	Free RadicalsIBA 10/2008
1	Superoxide DismutaseIBA 10/2008
1	Glutathione Transferase (Glutathione S-Transferase)IBA 10/2008
1	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 10/2008
1	Glutathione PeroxidaseIBA 10/2008
1	FucosyltransferasesIBA 07/2008

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2012